Matches in SemOpenAlex for { <https://semopenalex.org/work/W2411872125> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2411872125 endingPage "505" @default.
- W2411872125 startingPage "493" @default.
- W2411872125 abstract "Recently, the canine IBD activity index (CIBDAI) was developed for evaluation of the severity of illness, therapeutic strategies, and efficacy of therapy. The aim of the present study was to assess the severity of illness and the therapeutic strategy in dogs with IBD by the use of CIBDAI, serum albumin concentration, and histologic score (HPEG). Furthermore the use of CIBDAI and the efficacy of therapy in a prospective study during a 3 month treatment period were evaluated. Twentyone dogs with inflammatory bowel disease (lymphocytic-plasmacytic enteritis and enterocolitis) were examined in this study. In 11 dogs with IBD the severity of illness was assessed as low, according to CIBDAI and HPEG (CIBDAI score 4 or between 5 and 10 with HPEG score between 1 and 1.5). Six dogs were treated with hypoallergenic diet (Group D), five dogs were treated with hypoallergenic diet and metronidazole (15.6-22,3 mg/kg/day) (Group M). In 10 dogs with IBD the severity of illness was assessed as high (CIBDAI <10, or CIBDAI between 5 and 10 with HPEG score between 2 and 3 or hypoalbuminemia (< or = 2.5 g/dl)). This group (Group I) was treated with immunosuppressive therapy. Treatment consisted of prednisolone (n=10; 0.9-2 mg/kg/day), azathioprine (n=5; 0.9-2.3 mg/kg/day), sulfasalazine (n=4; 18.2-25 mg/kg/day) and hypoallergenic diet (n=10). Efficacy of therapy was evaluated prospectively 3 times in a 12 weeks treatment period. Remission (CIBDAI score < 4) indicated good therapeutic response, chronic or recurrent disease (CIBDAI score persistent or recurrent > or =4) indicated poor therapeutic response. Age, CIBDAI score and HPEG score were significantly different in IBD dogs with low severity of illness (age: median 60 months; CIBDAI score: median 5; HPEG score: median (1) and IBD dogs with high severity of illness (age: median 90 months; CIBDAI score: median 9.5; HPEG score: median 2.25) (p = 0.0101 and p = 0.0099, respectively). The presence of hypoalbuminemia was not significantly different between these two groups (p = 0.3108). There was no significant correlation between CIBDAI score and serum albumin concentration (r = 0.0394; p = 0.0802) or between CIBDAI score and HPEG score (r = 0.2587; p = 0.2574). In the treatment groups, HPEG score was only significantly different between D-group and group I (p < 0.01). The CIBDAI score decreased significantly in group I after 4 weeks of treatment (median 4th week: 3; p < 0.05), and in the D-group after 8 weeks of treatment (median 8 week 1; p < 0.05). No significant decrease of CIBDAI score was seen in the M-group (median 12th week: 1.75; p > 0.05). All dogs in group D, four of five dogs in group M, and six from ten dogs in group I went into remission. Poor therapeutic response (1 dog in group M and 5 dogs in group I; one dog died) was seen in 6 dogs, where as 15 dogs showed good therapeutic response. There was no significant association between efficacy of therapy and age (p = 0.8455), CIBDAI score (p = 0.3293), or serum albumin concentraton (p = 0.8455). Poor therapeutic response was weekly associated with HPEG score > or =2 (p = 0.0635). Using CIBDAI in dogs with IBD as a single parameter to assess the severity of illness and the therapeutic response, misinterpretations are possible. The assessment of the severity of illness by the combination of CIBAI, HPEG, and serum albumin concentration is leading to adaequate therapeutic results. Dogs with low grade IBD benefit from hypoallergenic diet, whereas dogs with high grade IBD benefit from immunosuppressive therapy. The effect of antibiotic treatment is questionable." @default.
- W2411872125 created "2016-06-24" @default.
- W2411872125 creator A5015553521 @default.
- W2411872125 creator A5058968945 @default.
- W2411872125 creator A5063866639 @default.
- W2411872125 date "2006-12-19" @default.
- W2411872125 modified "2023-09-26" @default.
- W2411872125 title "[Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease]." @default.
- W2411872125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17172138" @default.
- W2411872125 hasPublicationYear "2006" @default.
- W2411872125 type Work @default.
- W2411872125 sameAs 2411872125 @default.
- W2411872125 citedByCount "9" @default.
- W2411872125 countsByYear W24118721252012 @default.
- W2411872125 countsByYear W24118721252013 @default.
- W2411872125 countsByYear W24118721252015 @default.
- W2411872125 countsByYear W24118721252017 @default.
- W2411872125 countsByYear W24118721252019 @default.
- W2411872125 countsByYear W24118721252022 @default.
- W2411872125 countsByYear W24118721252023 @default.
- W2411872125 crossrefType "journal-article" @default.
- W2411872125 hasAuthorship W2411872125A5015553521 @default.
- W2411872125 hasAuthorship W2411872125A5058968945 @default.
- W2411872125 hasAuthorship W2411872125A5063866639 @default.
- W2411872125 hasConcept C126322002 @default.
- W2411872125 hasConcept C203014093 @default.
- W2411872125 hasConcept C207480886 @default.
- W2411872125 hasConcept C2776009029 @default.
- W2411872125 hasConcept C2778260677 @default.
- W2411872125 hasConcept C2779134260 @default.
- W2411872125 hasConcept C2780510475 @default.
- W2411872125 hasConcept C2780717550 @default.
- W2411872125 hasConcept C30036603 @default.
- W2411872125 hasConcept C71924100 @default.
- W2411872125 hasConcept C90924648 @default.
- W2411872125 hasConceptScore W2411872125C126322002 @default.
- W2411872125 hasConceptScore W2411872125C203014093 @default.
- W2411872125 hasConceptScore W2411872125C207480886 @default.
- W2411872125 hasConceptScore W2411872125C2776009029 @default.
- W2411872125 hasConceptScore W2411872125C2778260677 @default.
- W2411872125 hasConceptScore W2411872125C2779134260 @default.
- W2411872125 hasConceptScore W2411872125C2780510475 @default.
- W2411872125 hasConceptScore W2411872125C2780717550 @default.
- W2411872125 hasConceptScore W2411872125C30036603 @default.
- W2411872125 hasConceptScore W2411872125C71924100 @default.
- W2411872125 hasConceptScore W2411872125C90924648 @default.
- W2411872125 hasIssue "11-12" @default.
- W2411872125 hasLocation W24118721251 @default.
- W2411872125 hasOpenAccess W2411872125 @default.
- W2411872125 hasPrimaryLocation W24118721251 @default.
- W2411872125 hasRelatedWork W1931031802 @default.
- W2411872125 hasRelatedWork W2009292320 @default.
- W2411872125 hasRelatedWork W2020821729 @default.
- W2411872125 hasRelatedWork W2027590052 @default.
- W2411872125 hasRelatedWork W2032388308 @default.
- W2411872125 hasRelatedWork W2045384054 @default.
- W2411872125 hasRelatedWork W2046230132 @default.
- W2411872125 hasRelatedWork W2051455409 @default.
- W2411872125 hasRelatedWork W2052730385 @default.
- W2411872125 hasRelatedWork W2059931557 @default.
- W2411872125 hasRelatedWork W2065843773 @default.
- W2411872125 hasRelatedWork W2071799261 @default.
- W2411872125 hasRelatedWork W2074280408 @default.
- W2411872125 hasRelatedWork W2083050654 @default.
- W2411872125 hasRelatedWork W2134643141 @default.
- W2411872125 hasRelatedWork W2151219999 @default.
- W2411872125 hasRelatedWork W2179042236 @default.
- W2411872125 hasRelatedWork W2180023734 @default.
- W2411872125 hasRelatedWork W2795532333 @default.
- W2411872125 hasRelatedWork W1984290997 @default.
- W2411872125 hasVolume "119" @default.
- W2411872125 isParatext "false" @default.
- W2411872125 isRetracted "false" @default.
- W2411872125 magId "2411872125" @default.
- W2411872125 workType "article" @default.